--:-- ET
ETF analysis

Invesco NASDAQ Future Gen 200 ETF (QQQS) holdings & weights

Per-holding contribution · concentration · sector skew — a deep read

US-listed

25 identified stocks · net exposure / NAV 17.31%. Display weights are normalized to 100%; calculations retain original exposures without an additional leverage multiplier. Cash and unallocated contracts are excluded from stock attribution.

Weight and calculation basis

25 identified stocks · net exposure / NAV 17.31%. Display weights are normalized to 100%; calculations retain original exposures without an additional leverage multiplier. Cash and unallocated contracts are excluded from stock attribution.

+0.05%p
Theoretical day return
44.7%
Top-10 weight
409
Concentration HHI (Low)
Health Care
Top sector

Today's summary

On a constituent basis, Invesco NASDAQ Future Gen 200 ETF's theoretical return is +0.05%p. Today's biggest hero is Alphatec, contributing +0.03%p (return +4.42%). The biggest suspect dragging it down is AtriCure, at +0.02%p.

Its top 10 holdings make up about 44.7% of the fund. The concentration index (HHI) is 409 — Low — evenly diversified, and the largest sector is Health Care (47%). The higher the concentration, the more one stock or sector drives the whole ETF's return.

Structural health

A five-axis read on how this fund is built. It is not a return forecast or a recommendation, and a low score does not mean a bad fund — leveraged products score low by design. Each axis shows the figure behind it.

85/ 100
ASimple & diversified
DiversificationHHI 40988

Concentration is below 1,500 (409), so no single holding dominates.

Sector balanceHealth Care 47%64

Health Care is 47%, a clear tilt. That industry's swings will drive the fund.

Structural simplicityPhysical, 1x100

A plain 1x physical fund holding the shares themselves — no structural drift from how long you hold it.

We don't have cost, fund size for Invesco NASDAQ Future Gen 200 ETF yet, so those axes are excluded and the score is based on the other 3. Scoring a missing figure as zero would grade our data collection, not the fund.

Concentration and diversification

Structural health

A five-axis read on how this fund is built. It is not a return forecast or a recommendation, and a low score does not mean a bad fund — leveraged products score low by design. Each axis shows the figure behind it.

85/ 100
ASimple & diversified
DiversificationHHI 40988

Concentration is below 1,500 (409), so no single holding dominates.

Sector balanceHealth Care 47%64

Health Care is 47%, a clear tilt. That industry's swings will drive the fund.

Structural simplicityPhysical, 1x100

A plain 1x physical fund holding the shares themselves — no structural drift from how long you hold it.

We don't have cost, fund size for Invesco NASDAQ Future Gen 200 ETF yet, so those axes are excluded and the score is based on the other 3. Scoring a missing figure as zero would grade our data collection, not the fund.

Top 20 holdings

Weights are normalized to 100% of absolute exposures across analysed positions, including positions outside this top list. Cash, collateral and unverified assets are excluded. Contributions retain original signed NAV exposures; leverage is not applied twice.

Normalized to 100% of analysed positions

Weights are normalized to 100% of absolute exposures across analysed positions, including positions outside this top list. Cash, collateral and unverified assets are excluded. Contributions retain original signed NAV exposures; leverage is not applied twice.

Tile size = weight, colour = the day's return (deeper = larger). Covers the top 25 holdings, 17.3% of the fund. Labels are dropped where a tile is too small; hover any tile for its name and figures.
#HoldingWeight
1QTREX QuantumQTEX6.07%
2Iovance BiotherapeuticsIOVA5.55%
3Pacira BioSciencesPCRX4.68%
4Pacific Biosciences of CaliforniaPACB4.27%
5Myriad GeneticsMYGN4.16%
6SynapticsSYNA4.04%
7GoProGPRO3.99%
8MaxLinearMXL3.99%
9Skyworks SolutionsSWKS3.99%
10Turtle BeachTBCH3.99%
11InogenINGN3.87%
12AtriCureATRC3.87%
13Heron TherapeuticsHRTX3.81%
14TTECTTEC3.75%
15ChipMOS TECHNOLOGIESIMOS3.76%
1610x GenomicsTXG3.75%
17AlphatecATEC3.76%
18SonosSONO3.70%
19JOYYJOYY3.70%
20Commvault SystemsCVLT3.64%

Holdings below 0.5% or outside the top list are folded into “Others” and omitted above.

Where the weight sits — sector mix

Listed equity weights summed by sector and normalized to 100%. Each band is one sector's share.

Health Care46.6%
Information Technology30.2%
Industrials7.9%
Consumer Discretionary7.7%
Communication Services4.0%
Consumer Staples3.7%
Industry breakdown
Medical/Dental Instruments17.2%
Semiconductors15.8%
Biotechnology: Pharmaceutical Preparations12.0%
Biotechnology: Laboratory Analytical Instruments11.6%
EDP Services7.2%
Computer Software: Prepackaged Software7.2%
Biotechnology: Biological Products (No Diagnostic Substances)5.5%
Biotechnology: In Vitro & In Vivo Diagnostic Substances4.2%
Industrial Machinery/Components4.0%
Telecommunications Equipment4.0%
Industrial Specialties3.9%
Professional Services3.8%
Consumer Electronics/Appliances3.7%
Concentration at a glanceHHI 409well spread
spread1,0001,8002,500concentrated

HHI sums the squared weights. The more it leans on a few names, the higher it goes — and the more the whole ETF moves with them.

How concentrated is it

Concentration (HHI) is low at 409, with the top 10 holdings at just 44.7% of equity weight. No single name can dominate the fund.

Good for damping single-stock risk — and equally, a big winner inside gets diluted.

HHI squares each weight and sums them: 10,000 means one stock is everything, and the more evenly spread the holdings, the closer it falls to zero.

Where the sector weight sits

Sector weights run Health Care(47%) · Information Technology(30%) · Industrials(8%). At 47%, the leading sector is a clear tilt.

Expect it to ride that industry's cycle — ahead of the index in good stretches, behind in bad ones.

Weights above sum the individually listed equities and normalize that equity total to 100%.

How much it overlaps others

Even its closest peer, ETHO, overlaps only 15% (4 shared names).

Funds filed under the same label can hold quite different companies, so pairing this one with another may genuinely spread risk.

What it is made of

Equities are 17.3% of the fund, the rest swaps and cash — index exposure built synthetically rather than by owning the shares, which adds counterparty risk.

This page is not investment advice. Investment decisions and responsibility are your own.

QQQS comments

Leave a one-line take on Invesco NASDAQ Future Gen 200 ETF. No account — just a nickname and a code to delete it later.

Loading…

Similar ETFs

Picked by how much their actual holdings overlap. The higher the overlap, the less diversification you get from owning both.